ENT M&A Advisory
For multi-physician otolaryngology groups, integrated practices with audiology and allergy services, and ENT practices with surgical center affiliations. PE consolidation in ENT has accelerated since 2020, with selective platform buyers actively acquiring quality groups.
Speak with an advisor: (800) 815-0590How We Help ENT Sellers
Capital Partners' M&A framework is built around the specific dynamics of middle-market specialty practice transactions. The three engagement profiles below cover most of how ent practice owners come to us.
Three to fifteen physician practices with established procedural volume, sub-specialty mix, and operational infrastructure. The middle-market ENT buyer landscape, while less mature than dental or GI, has solidified meaningfully.
Discuss your practice →ENT practices with established audiology programs (hearing aids, dispensing, diagnostics) achieve diversified revenue profiles. Audiology revenue is high-margin recurring revenue that buyers value.
Discuss your platform →Practices integrated with allergy testing & immunotherapy, balance/dizziness diagnostics, and surgical center affiliation generate premium valuations through service breadth and ancillary EBITDA.
Discuss your group →Market Context
ENT consolidation, while smaller in scale than the largest healthcare specialty markets, has grown meaningfully since 2020. Platforms including ENT and Audiology Associates, Houston ENT & Allergy Services, Pinnacle ENT, and ENT Family of Companies actively acquire quality groups. The buyer pool is more selective than in larger specialty markets but real institutional interest exists.
The Capital Partners Approach
The smaller and more selective ENT platform pool means buyer-fit evaluation is particularly important. Not every quality ENT practice will be a fit for every platform — geographic, sub-specialty, and cultural alignment all matter. A deliberate process is critical to finding the right fit at the right terms rather than accepting the first credible offer.
ENT practices considering institutional capital should think about the platform's growth strategy, not just the headline valuation. Rolled equity in the right ENT platform can be exceptionally valuable; rolled equity in the wrong platform can disappoint over the hold period.
Valuation Drivers
ENT practice valuation is driven by a specific set of operational, clinical, and structural factors. Below are the elements buyers evaluate most carefully when developing valuation and offer terms.
Hearing aid dispensing volume, audiologist count, and audiology EBITDA contribution all factor into valuation. Audiology is among the highest-margin revenue in ENT.
In-house allergy testing and immunotherapy programs contribute meaningful recurring revenue. Allergy practice integration is increasingly common in modern ENT platforms.
Surgical case volume, complexity, and case mix all factor into evaluation. ASC affiliation or ownership adds meaningful value.
Sub-specialty depth across pediatric ENT, head and neck oncology, rhinology, otology, and facial plastics influences buyer interest. Sub-specialty diversity is generally valued.
Physician count, tenure, age distribution, and post-close commitments all factor into buyer evaluation. Physician retention is a primary buyer concern in ENT.
Market position and referral network density in the metropolitan area influence valuation. Buyers prefer practices with demonstrated market presence.
Begin a Conversation
The most useful next step is a confidential conversation. We'll listen to your situation, give you a directional view of where your practice sits in the current market, and explain how a Capital Partners engagement would actually run. Every conversation begins under NDA.
(800) 815-0590